Oncology

radioligand-therapies-reshaping-the-neuroendocrine-tumors-treatment

Articles

From Beta to Alpha Emitters: Radioligand Therapies Reshaping the Neuroendocrine Tumors Treatment Landscape

Explore More...
medtech-news-for-stryker-qiagen-evolution-optiks-nexalin

Stryker’s LIFEPAK 35 Monitor/Defibrillator; Qiagen’s QIAstat-Dx Respiratory Panel; Evolution Optiks’s 510(k) Clearance; Microbot Medical Endovascular Surgical Robot Trial; Nexalin’s Insomnia and Anxiety Therapy Headset Clinical Trial; KORU Medical Systems’ Study With Commercialized Oncology Biologics

pharma-news-for-moderna-scemblix-kite-astellas

Moderna’s mRESVIA(R) FDA Approval; Novartis Scemblix® Phase III Data; Kite’s Tecartus for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia; Astellas’ Zolbetuximab Biologics License Application; CHMP Recommends AstraZeneca’s Tagrisso

chinese-pd-1-pd-l1-key-players

Rapid Global Expansion of Chinese PD-1/PD-L1 Key Players

key-developments-in-pd-l1-inhibitors

The Journey of PD-(L)1 Inhibitors: Milestones and Breakthroughs

pharma-news-for-astrazeneca-biogen-altrubio-gsk

AstraZeneca’s Tropion-Lung01 Phase III Trial Positive Outcomes; Biogen’s LEQEMBI South Korea Approval; AltruBio’s $225M Series B Funding; GSK’s Depemokimab Positive Phase III Severe Asthma Results; Roche’s Inavolisib FDA Breakthrough Therapy Designation

pharma-news-for-amgen-bms-abbvie-eisai

Amgen’s IMDELLTRA FDA Approval; J&J’s Proteologix Acquisition; Bristol Myers Squibb’s BREYANZI FDA Approval; AbbVie and Gilgamesh Pharmaceuticals’ Agreement; Eisai’s LEQEMBI FDA Fast Track Status

gsk-and-iteos-collaboration-for-belrestotug

GSK and iTeos Alliance Boosts Belrestotug Prospects in TIGIT Space

medtech-news-for-siemens-orthoxel-valneva

Siemens Healthineers USD 314 Million Investment; Samsung Medison’s Sonio Acquisition; Leo Cancer Care’s Upright Technology Clearance; OrthoXel’s Vertex Hip Fracture Nail FDA 510 (k) Clearance; SPR Therapeutics’ PNS Pain Relief Device Positive Data; Valneva’s Chikungunya Vaccine Positive Pivotal Phase III Data

pharma-news-for-takeda-ac-immune-eli-lilly-bristol-myers-squibb

Takeda and AC Immune’s Alzheimer’s Deal; Eli Lilly’s Donanemab FDA Review; Bristol Myers Squibb’s Phase III CheckMate -73L Trial Result; Regeneron Pharmaceuticals’ Dupixent sBLA; Excision BioTherapeutics’ EBT-101 Phase I/II Trial Results

medtech-news-for-monteris-vesica-health-anaut-geneoscopy

Monteris Smallest Brain Laser Probe Launch; Vesica Health’s AssureMDx Test Launch; Anaut’s Eureka α Japanese Regulatory Approval; Geneoscopy’s Labcorp-Partnered Colon Cancer Test FDA Approval; Novel Omeza® OCM™ Diabetic Foot Ulcers Results; LEO Pharma Phase III Plaque Psoriasis Trial Results

nanomedicine-future-growth-outlook

Nanomedicine Market: Evaluating the Pioneering Innovations and Future Growth Prospects

pharma-news-for-boehringer-ingelheim-novartis-astellas-pfizer

Boehringer Ingelheim’s Diabetic Macular Ischemia Study; Novartis’ Mariana Oncology Acquisition; Astellas and Poseida Therapeutics Partnership; Prime Medicine’s PM359 IND; Pfizer’s TIVDAK FDA Approval

emerging-therapies-for-cancer-cachexia-treatment

Insights into Cancer Cachexia Treatment: Unraveling the Mystery

pharma-news-for-x4-pharmaceuticals-ono-beigene-sanofi

X4 Pharmaceuticals’ XOLREMDI FDA Approval; ONO to Acquire Deciphera Pharmaceuticals; Johnson & Johnson’s SIRTURO CHMP Approval; BeiGene’s Tislelizumab EC Approval; Sanofi’s Rilzabrutinib LUNA 3 Phase III Trial

lutathera-for-gep-net-treatment

Novartis’ LUTATHERA for GEP-NET Treatment: Ray of Hope for Pediatric Patients

pharma-news-for-ipsen-synox-roche-abbvie

Ipsen and Skyhawk Therapeutics Partnership; SynOx Therapeutics’ Phase III Trial; Roche’s Alecensa FDA Approval; AbbVie’s RINVOQ Phase III SELECT-GCA Trial; AskBio’s AB-1002 FDA Fast Track Designation

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Days
loader